KDA
Kuwait — KDA
MoH Medical Device Registration with GHC Reference Route
Authority
Kuwait Drug and Food Control / Ministry of Health (KDFC)
Enforced
2017 (KDFC medical device circulars)
Legal framework
Ministry of Health KDFC medical device registration circulars; Gulf Health Council (GHC) Centralized Registration Procedure available as a regional pathway across GCC. Cyber overlay relies on Kuwait Data Privacy Protection Regulation (CITRA, 2021) and CITRA's national cybersecurity strategy.
Scope
All medical devices placed on the Kuwaiti market. GCC manufacturers may use the centralised GHC route covering KW, SA, AE, BH, OM, QA in a single dossier.
Pre-market
Reliance-based on reference-country approvals (FDA, CE, Health Canada, TGA, PMDA, MHRA). No standalone medical-device cybersecurity guideline; connected-device posture inherited from reference-country evidence.
Post-market
Vigilance reporting to KDFC; CITRA handles ICT-incident coordination for connected devices in healthcare networks.
SBOM
Not specifiedNot required by KDFC today; CE/FDA SBOMs accepted as supporting evidence.
Vulnerability disclosure
CITRA National CERT for ICT incidents; no medical-device-specific CVD requirement.
Penalty
Registration cancellation, market withdrawal, fines under MoH and CITRA orders.
Unique requirements
- 01Kuwaiti authorised local agent
- 02Arabic-language IFU and labelling
- 03GHC route subject to per-country acceptance
Highlights
- GHC central route covers 6 GCC markets in one dossier
- Reference-country reliance is the dominant route
- CITRA data-protection overlay for connected devices
Aligns with
Timeline
-
2017
KDFC medical device registration circulars
-
2021
CITRA Data Privacy Protection Regulation in force
-
2024
GHC centralised registration scope expanded
Key documents
Related markets
Frequently asked about Kuwait
Is SBOM required for medical devices in Kuwait?
Not specified. Not required by KDFC today; CE/FDA SBOMs accepted as supporting evidence.
What does KDA require for pre-market cybersecurity?
Reliance-based on reference-country approvals (FDA, CE, Health Canada, TGA, PMDA, MHRA). No standalone medical-device cybersecurity guideline; connected-device posture inherited from reference-country evidence.
What are the post-market cybersecurity obligations under KDA?
Vigilance reporting to KDFC; CITRA handles ICT-incident coordination for connected devices in healthcare networks.
What is the penalty for non-compliance with KDA cybersecurity rules?
Registration cancellation, market withdrawal, fines under MoH and CITRA orders.
How much of my FDA cybersecurity package is reusable in Kuwait?
Roughly 80% — an editorial estimate based on overlapping evidence requirements (threat model, SBOM, security risk assessment, pen-test report).